Cancer

At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Kolling Institute Tumour Bank

Events, News and Seminars

Researchers to join leading cancer care centres in exciting new trial

Researchers to join leading cancer care centres in exciting new trial

Researchers from the Kolling Institute and Royal North Shore Hospital will help drive a new project ..... Read more

Category: Funding support, Research Excellence

Exciting study to investigate new treatment for acute myeloid leukaemia

Exciting study to investigate new treatment for acute myeloid leukaemia

The Cancer Council NSW today announced funding for a new stem cell team at the Kolling Institute to ..... Read more

Category: Funding support, Research Excellence

New cutting-edge technology coming to the Kolling

New cutting-edge technology coming to the Kolling

The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leadi..... Read more

Category: Research Excellence, World-leading technology